Radiomics has shown great promise in detecting important genetic markers involved in cancers such as gliomas, as specific mutations produce subtle but characteristic changes in tumor texture and morphology. In particular, mutations in IDH (isocitrate dehydrogenase) are well-known to be important prognostic markers in glioma patients. Most classification approaches using radiomics, however, involve complex hand-crafted feature sets or “black-box” methods such as deep neural networks, and therefore lack interpretability. Here, we explore the application of simple graph-theoretical methods based on the minimum-spanning tree (MST) to radiomics data, in order to detect IDH mutations in gliomas. This is done using a hypothesis testing approach. T...
The isocitrate dehydrogenase (IDH) gene mutation is an essential biomarker for the diagnosis and pro...
Isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status are important prognostic marker...
Gliomas are the most frequently occurring primary brain tumors. Determination of the IDH-mutation (I...
Patients with gliomas, isocitrate dehydrogenase 1 (IDH1) mutation status have been studied as a prog...
This study aimed to investigate the potential of quantitative radiomic data extracted from conventio...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
Purpose. Preoperative prediction of isocitrate dehydrogenase 1 (IDH1) mutation in lower-grade glioma...
BACKGROUND AND PURPOSE: The World Health Organization has recently placed new emphasis on the integr...
Background and purposeSemantic imaging features have been used for molecular subclassification of hi...
Background and purposeSemantic imaging features have been used for molecular subclassification of hi...
BACKGROUND: Combining MRI techniques with machine learning methodology is rapidly gaining attention ...
Diffuse gliomas are the most common malignant primary brain tumors. Identification of isocitrate deh...
Glioma is a common malignant brain tumor with distinct survival among patients. The isocitrate dehyd...
Isocitrate dehydrogenase (IDH) mutant and wildtype glioblastoma multiforme (GBM) often show overlapp...
The isocitrate dehydrogenase (IDH) gene mutation is an essential biomarker for the diagnosis and pro...
Isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status are important prognostic marker...
Gliomas are the most frequently occurring primary brain tumors. Determination of the IDH-mutation (I...
Patients with gliomas, isocitrate dehydrogenase 1 (IDH1) mutation status have been studied as a prog...
This study aimed to investigate the potential of quantitative radiomic data extracted from conventio...
International audienceGliomas are among the most common types of central nervous system (CNS) tumors...
Purpose. Preoperative prediction of isocitrate dehydrogenase 1 (IDH1) mutation in lower-grade glioma...
BACKGROUND AND PURPOSE: The World Health Organization has recently placed new emphasis on the integr...
Background and purposeSemantic imaging features have been used for molecular subclassification of hi...
Background and purposeSemantic imaging features have been used for molecular subclassification of hi...
BACKGROUND: Combining MRI techniques with machine learning methodology is rapidly gaining attention ...
Diffuse gliomas are the most common malignant primary brain tumors. Identification of isocitrate deh...
Glioma is a common malignant brain tumor with distinct survival among patients. The isocitrate dehyd...
Isocitrate dehydrogenase (IDH) mutant and wildtype glioblastoma multiforme (GBM) often show overlapp...
The isocitrate dehydrogenase (IDH) gene mutation is an essential biomarker for the diagnosis and pro...
Isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status are important prognostic marker...
Gliomas are the most frequently occurring primary brain tumors. Determination of the IDH-mutation (I...